Genetic anticipation of breast cancer among BRCA1 / BRCA2 mutation carriers: A retrospective study

Author:

Kedmi Aviya1,Kadouri Luna2,Sagy Iftach3,Hamburger Tamar2,Levin Gabriel4ORCID,Zimhony‐Nissim Noa3,Peretz Tamar2

Affiliation:

1. Joyce and Irving Medical School of the Faculty of Health Sciences at Ben‐Gurion University of the Negev Beer Sheva Israel

2. Sharett Institute of Oncology Hadassah‐Hebrew University Medical Center Jerusalem Israel

3. Soroka Clinical Research Center Soroka University Medical Center Beer Sheva Israel

4. Department of Gynecologic Oncology Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem Jerusalem Israel

Publisher

Wiley

Subject

Obstetrics and Gynecology,General Medicine

Reference25 articles.

1. Breast Cancer Treatment

2. Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

3. Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms

4. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

5. Risk assessment, genetic counseling, and genetic testing for BRCA‐related cancer: systematic review to update the U.S. Preventive services task force recommendation;Nelson HD;Ann Intern Med,2013

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status;Breast Cancer Research and Treatment;2023-02-02

2. Modern interpretation of risk factors in breast cancer of women;Journal of Mind and Medical Sciences;2022-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3